nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.484	1	CbGbCtD
Levofloxacin—SLC22A6—Organic anion transport—SLC22A12—nephrolithiasis	0.0259	0.166	CbGpPWpGaD
Levofloxacin—SLC22A2—nephron—nephrolithiasis	0.0222	0.262	CbGeAlD
Levofloxacin—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0213	0.137	CbGpPWpGaD
Levofloxacin—Airway obstruction NOS—Hydrochlorothiazide—nephrolithiasis	0.0152	0.0552	CcSEcCtD
Levofloxacin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0121	0.0774	CbGpPWpGaD
Levofloxacin—Obstructive airways disorder—Hydrochlorothiazide—nephrolithiasis	0.011	0.0399	CcSEcCtD
Levofloxacin—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0101	0.0646	CbGpPWpGaD
Levofloxacin—CYP1A2—urine—nephrolithiasis	0.00792	0.0936	CbGeAlD
Levofloxacin—Local swelling—Hydrochlorothiazide—nephrolithiasis	0.00715	0.0259	CcSEcCtD
Levofloxacin—Electrolyte imbalance—Hydrochlorothiazide—nephrolithiasis	0.00598	0.0217	CcSEcCtD
Levofloxacin—CYP3A4—urine—nephrolithiasis	0.00573	0.0678	CbGeAlD
Levofloxacin—Leg pain—Hydrochlorothiazide—nephrolithiasis	0.00541	0.0196	CcSEcCtD
Levofloxacin—SLC22A6—nephron tubule—nephrolithiasis	0.0052	0.0615	CbGeAlD
Levofloxacin—SLC22A2—nephron tubule—nephrolithiasis	0.00479	0.0567	CbGeAlD
Levofloxacin—SLC22A6—cortex of kidney—nephrolithiasis	0.00445	0.0526	CbGeAlD
Levofloxacin—SLC22A2—renal system—nephrolithiasis	0.00436	0.0515	CbGeAlD
Levofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00426	0.0273	CbGpPWpGaD
Levofloxacin—SLC22A2—kidney—nephrolithiasis	0.00421	0.0498	CbGeAlD
Levofloxacin—SLC22A2—cortex of kidney—nephrolithiasis	0.0041	0.0485	CbGeAlD
Levofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00396	0.0254	CbGpPWpGaD
Levofloxacin—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.00393	0.0143	CcSEcCtD
Levofloxacin—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.00389	0.0141	CcSEcCtD
Levofloxacin—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.0037	0.0134	CcSEcCtD
Levofloxacin—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.00363	0.0132	CcSEcCtD
Levofloxacin—SLC22A4—nephron tubule—nephrolithiasis	0.00355	0.042	CbGeAlD
Levofloxacin—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00337	0.0122	CcSEcCtD
Levofloxacin—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00326	0.0118	CcSEcCtD
Levofloxacin—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.00326	0.0118	CcSEcCtD
Levofloxacin—SLC22A4—renal system—nephrolithiasis	0.00323	0.0382	CbGeAlD
Levofloxacin—SLC22A4—kidney—nephrolithiasis	0.00312	0.0369	CbGeAlD
Levofloxacin—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00308	0.0112	CcSEcCtD
Levofloxacin—Stinging—Hydrochlorothiazide—nephrolithiasis	0.00308	0.0112	CcSEcCtD
Levofloxacin—SLC22A4—cortex of kidney—nephrolithiasis	0.00304	0.036	CbGeAlD
Levofloxacin—Numbness—Hydrochlorothiazide—nephrolithiasis	0.00301	0.0109	CcSEcCtD
Levofloxacin—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.00288	0.0105	CcSEcCtD
Levofloxacin—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.00282	0.0102	CcSEcCtD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00279	0.0179	CbGpPWpGaD
Levofloxacin—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00276	0.01	CcSEcCtD
Levofloxacin—Gout—Hydrochlorothiazide—nephrolithiasis	0.00267	0.00971	CcSEcCtD
Levofloxacin—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00261	0.00946	CcSEcCtD
Levofloxacin—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00929	CcSEcCtD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00255	0.0164	CbGpPWpGaD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00255	0.0164	CbGpPWpGaD
Levofloxacin—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00254	0.00923	CcSEcCtD
Levofloxacin—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0025	0.00906	CcSEcCtD
Levofloxacin—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00891	CcSEcCtD
Levofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00242	0.0155	CbGpPWpGaD
Levofloxacin—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00236	0.00856	CcSEcCtD
Levofloxacin—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00234	0.00851	CcSEcCtD
Levofloxacin—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00228	0.00828	CcSEcCtD
Levofloxacin—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00226	0.0082	CcSEcCtD
Levofloxacin—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00226	0.0082	CcSEcCtD
Levofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00225	0.0144	CbGpPWpGaD
Levofloxacin—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00222	0.00807	CcSEcCtD
Levofloxacin—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00209	0.0076	CcSEcCtD
Levofloxacin—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00208	0.00756	CcSEcCtD
Levofloxacin—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00206	0.00749	CcSEcCtD
Levofloxacin—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00206	0.00749	CcSEcCtD
Levofloxacin—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00205	0.00746	CcSEcCtD
Levofloxacin—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00205	0.00742	CcSEcCtD
Levofloxacin—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00203	0.00736	CcSEcCtD
Levofloxacin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00201	0.0129	CbGpPWpGaD
Levofloxacin—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00201	0.00729	CcSEcCtD
Levofloxacin—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00194	0.00703	CcSEcCtD
Levofloxacin—CYP1A2—renal system—nephrolithiasis	0.00194	0.0229	CbGeAlD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00194	0.0124	CbGpPWpGaD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00194	0.0124	CbGpPWpGaD
Levofloxacin—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00192	0.00697	CcSEcCtD
Levofloxacin—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00192	0.00697	CcSEcCtD
Levofloxacin—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00191	0.00694	CcSEcCtD
Levofloxacin—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00191	0.00694	CcSEcCtD
Levofloxacin—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.0019	0.00691	CcSEcCtD
Levofloxacin—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0019	0.00691	CcSEcCtD
Levofloxacin—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00188	0.00683	CcSEcCtD
Levofloxacin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00187	0.012	CbGpPWpGaD
Levofloxacin—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00187	0.00677	CcSEcCtD
Levofloxacin—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00182	0.00661	CcSEcCtD
Levofloxacin—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00181	0.00658	CcSEcCtD
Levofloxacin—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00181	0.00658	CcSEcCtD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0018	0.0116	CbGpPWpGaD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0018	0.0116	CbGpPWpGaD
Levofloxacin—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00178	0.00648	CcSEcCtD
Levofloxacin—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00178	0.00648	CcSEcCtD
Levofloxacin—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00175	0.00635	CcSEcCtD
Levofloxacin—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00172	0.00623	CcSEcCtD
Levofloxacin—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0017	0.00619	CcSEcCtD
Levofloxacin—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0017	0.00616	CcSEcCtD
Levofloxacin—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00166	0.00603	CcSEcCtD
Levofloxacin—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00166	0.00601	CcSEcCtD
Levofloxacin—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00165	0.00599	CcSEcCtD
Levofloxacin—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00164	0.00595	CcSEcCtD
Levofloxacin—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00163	0.00593	CcSEcCtD
Levofloxacin—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00163	0.00593	CcSEcCtD
Levofloxacin—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.0016	0.00582	CcSEcCtD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.0016	0.0103	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00159	0.0102	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00159	0.0102	CbGpPWpGaD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00158	0.0102	CbGpPWpGaD
Levofloxacin—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00158	0.00573	CcSEcCtD
Levofloxacin—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00157	0.00569	CcSEcCtD
Levofloxacin—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00154	0.00558	CcSEcCtD
Levofloxacin—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00153	0.00554	CcSEcCtD
Levofloxacin—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00147	0.00532	CcSEcCtD
Levofloxacin—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00147	0.00532	CcSEcCtD
Levofloxacin—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00146	0.00529	CcSEcCtD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00145	0.0093	CbGpPWpGaD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00145	0.0093	CbGpPWpGaD
Levofloxacin—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00145	0.00525	CcSEcCtD
Levofloxacin—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00144	0.00524	CcSEcCtD
Levofloxacin—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00143	0.00519	CcSEcCtD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00142	0.00911	CbGpPWpGaD
Levofloxacin—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00141	0.00513	CcSEcCtD
Levofloxacin—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00141	0.0051	CcSEcCtD
Levofloxacin—CYP3A4—renal system—nephrolithiasis	0.0014	0.0166	CbGeAlD
Levofloxacin—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00139	0.00503	CcSEcCtD
Levofloxacin—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00138	0.005	CcSEcCtD
Levofloxacin—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00137	0.00498	CcSEcCtD
Levofloxacin—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00137	0.00497	CcSEcCtD
Levofloxacin—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00137	0.00497	CcSEcCtD
Levofloxacin—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00136	0.00494	CcSEcCtD
Levofloxacin—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00136	0.00493	CcSEcCtD
Levofloxacin—CYP3A4—kidney—nephrolithiasis	0.00136	0.016	CbGeAlD
Levofloxacin—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00133	0.00483	CcSEcCtD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00132	0.00848	CbGpPWpGaD
Levofloxacin—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00132	0.00478	CcSEcCtD
Levofloxacin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00131	0.00476	CcSEcCtD
Levofloxacin—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.0013	0.00473	CcSEcCtD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.0013	0.00833	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.0013	0.00833	CbGpPWpGaD
Levofloxacin—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00128	0.00463	CcSEcCtD
Levofloxacin—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00126	0.00456	CcSEcCtD
Levofloxacin—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00125	0.00455	CcSEcCtD
Levofloxacin—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00125	0.00453	CcSEcCtD
Levofloxacin—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00124	0.00452	CcSEcCtD
Levofloxacin—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00124	0.00448	CcSEcCtD
Levofloxacin—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00121	0.00439	CcSEcCtD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00121	0.00776	CbGpPWpGaD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00121	0.00776	CbGpPWpGaD
Levofloxacin—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00119	0.0043	CcSEcCtD
Levofloxacin—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00117	0.00424	CcSEcCtD
Levofloxacin—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00116	0.00422	CcSEcCtD
Levofloxacin—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00112	0.00407	CcSEcCtD
Levofloxacin—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00111	0.00402	CcSEcCtD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0011	0.00705	CbGpPWpGaD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0011	0.00705	CbGpPWpGaD
Levofloxacin—ABCB1—nephron tubule—nephrolithiasis	0.00109	0.0129	CbGeAlD
Levofloxacin—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00109	0.00396	CcSEcCtD
Levofloxacin—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00108	0.0039	CcSEcCtD
Levofloxacin—Tension—Hydrochlorothiazide—nephrolithiasis	0.00107	0.00389	CcSEcCtD
Levofloxacin—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00107	0.00388	CcSEcCtD
Levofloxacin—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00106	0.00385	CcSEcCtD
Levofloxacin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00106	0.00383	CcSEcCtD
Levofloxacin—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00105	0.00381	CcSEcCtD
Levofloxacin—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00103	0.00373	CcSEcCtD
Levofloxacin—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00102	0.00371	CcSEcCtD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00102	0.00655	CbGpPWpGaD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00102	0.00655	CbGpPWpGaD
Levofloxacin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00101	0.00368	CcSEcCtD
Levofloxacin—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00101	0.00366	CcSEcCtD
Levofloxacin—Agitation—Hydrochlorothiazide—nephrolithiasis	0.001	0.00364	CcSEcCtD
Levofloxacin—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.000998	0.00362	CcSEcCtD
Levofloxacin—ABCB1—renal system—nephrolithiasis	0.000993	0.0117	CbGeAlD
Levofloxacin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.000985	0.00357	CcSEcCtD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000984	0.00631	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000984	0.00631	CbGpPWpGaD
Levofloxacin—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.000981	0.00356	CcSEcCtD
Levofloxacin—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000979	0.00355	CcSEcCtD
Levofloxacin—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000977	0.00355	CcSEcCtD
Levofloxacin—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.000965	0.0035	CcSEcCtD
Levofloxacin—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00096	0.00348	CcSEcCtD
Levofloxacin—ABCB1—kidney—nephrolithiasis	0.00096	0.0113	CbGeAlD
Levofloxacin—Cough—Hydrochlorothiazide—nephrolithiasis	0.000953	0.00346	CcSEcCtD
Levofloxacin—ABCB1—cortex of kidney—nephrolithiasis	0.000935	0.011	CbGeAlD
Levofloxacin—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000929	0.00337	CcSEcCtD
Levofloxacin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.000929	0.00337	CcSEcCtD
Levofloxacin—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.000929	0.00337	CcSEcCtD
Levofloxacin—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.000926	0.00336	CcSEcCtD
Levofloxacin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.000918	0.00333	CcSEcCtD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000915	0.00588	CbGpPWpGaD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000915	0.00588	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000914	0.00587	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000914	0.00587	CbGpPWpGaD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00091	0.00584	CbGpPWpGaD
Levofloxacin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000909	0.0033	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000903	0.0058	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000903	0.0058	CbGpPWpGaD
Levofloxacin—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000898	0.00326	CcSEcCtD
Levofloxacin—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000891	0.00323	CcSEcCtD
Levofloxacin—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000891	0.00323	CcSEcCtD
Levofloxacin—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.000883	0.00567	CbGpPWpGaD
Levofloxacin—Shock—Hydrochlorothiazide—nephrolithiasis	0.000877	0.00318	CcSEcCtD
Levofloxacin—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000872	0.00317	CcSEcCtD
Levofloxacin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00087	0.00316	CcSEcCtD
Levofloxacin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000861	0.00313	CcSEcCtD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000851	0.00546	CbGpPWpGaD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000851	0.00546	CbGpPWpGaD
Levofloxacin—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000849	0.00308	CcSEcCtD
Levofloxacin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000833	0.00302	CcSEcCtD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000815	0.00523	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000815	0.00523	CbGpPWpGaD
Levofloxacin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.000812	0.00295	CcSEcCtD
Levofloxacin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000806	0.00293	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000805	0.00517	CbGpPWpGaD
Levofloxacin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.0008	0.0029	CcSEcCtD
Levofloxacin—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000794	0.00288	CcSEcCtD
Levofloxacin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000792	0.00288	CcSEcCtD
Levofloxacin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000784	0.00285	CcSEcCtD
Levofloxacin—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000775	0.00281	CcSEcCtD
Levofloxacin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000768	0.00279	CcSEcCtD
Levofloxacin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000762	0.00277	CcSEcCtD
Levofloxacin—Pain—Hydrochlorothiazide—nephrolithiasis	0.000762	0.00277	CcSEcCtD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000759	0.00487	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000753	0.00483	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000753	0.00483	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000736	0.00473	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000736	0.00473	CbGpPWpGaD
Levofloxacin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000734	0.00267	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000729	0.00264	CcSEcCtD
Levofloxacin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000708	0.00257	CcSEcCtD
Levofloxacin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000704	0.00256	CcSEcCtD
Levofloxacin—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000704	0.00256	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000671	0.00431	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000656	0.00238	CcSEcCtD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000651	0.00418	CbGpPWpGaD
Levofloxacin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000639	0.00232	CcSEcCtD
Levofloxacin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00063	0.00229	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000614	0.00394	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000614	0.00394	CbGpPWpGaD
Levofloxacin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00061	0.00221	CcSEcCtD
Levofloxacin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000589	0.00214	CcSEcCtD
Levofloxacin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000567	0.00206	CcSEcCtD
Levofloxacin—Rash—Hydrochlorothiazide—nephrolithiasis	0.000562	0.00204	CcSEcCtD
Levofloxacin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000561	0.00204	CcSEcCtD
Levofloxacin—Headache—Hydrochlorothiazide—nephrolithiasis	0.000558	0.00203	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000558	0.00358	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000558	0.00358	CbGpPWpGaD
Levofloxacin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000529	0.00192	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000519	0.00333	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000519	0.00333	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.000517	0.00332	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000465	0.00299	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000465	0.00299	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000462	0.00297	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000462	0.00297	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000432	0.00278	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000432	0.00278	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000411	0.00264	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000411	0.00264	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000399	0.00256	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000385	0.00247	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000385	0.00247	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00037	0.00237	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000367	0.00235	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000335	0.00215	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000335	0.00215	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000308	0.00198	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GRHPR—nephrolithiasis	0.000267	0.00172	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000254	0.00163	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000254	0.00163	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—AGXT—nephrolithiasis	0.000238	0.00153	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000236	0.00152	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000236	0.00152	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000211	0.00135	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000211	0.00135	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—SLC26A1—nephrolithiasis	0.000203	0.0013	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—APRT—nephrolithiasis	0.000203	0.0013	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000168	0.00108	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000146	0.000937	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—AQP1—nephrolithiasis	0.000144	0.000927	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CHRM3—nephrolithiasis	0.000131	0.000838	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—AGXT—nephrolithiasis	0.00013	0.000836	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.000117	0.000748	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000111	0.00071	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—APRT—nephrolithiasis	0.000111	0.00071	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000104	0.000667	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GRHPR—nephrolithiasis	9e-05	0.000578	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—APRT—nephrolithiasis	8.83e-05	0.000567	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	8.83e-05	0.000567	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—AGXT—nephrolithiasis	8.02e-05	0.000515	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—AQP1—nephrolithiasis	7.88e-05	0.000506	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CHRM3—nephrolithiasis	7.13e-05	0.000458	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—APRT—nephrolithiasis	6.82e-05	0.000438	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	6.82e-05	0.000438	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—AQP1—nephrolithiasis	6.29e-05	0.000404	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CHRM3—nephrolithiasis	5.69e-05	0.000365	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—AQP1—nephrolithiasis	4.86e-05	0.000312	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CHRM3—nephrolithiasis	4.39e-05	0.000282	CbGpPWpGaD
